$2.83
arrow_drop_up1.07%Key Stats | |
---|---|
Open | $2.85 |
Prev. Close | $2.80 |
EPS | 37.48 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $4.05M |
LOW | HIGH | |
---|---|---|
Day Range | 2.77 | 2.87 |
52 Week Range | 2.25 | 64.27 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | 37.48 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)
Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
Avenue Therapeutics Announces Reverse Stock Split
Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024